VERSAMAB Trademark

Trademark Overview

On Tuesday, November 30, 2021, a trademark application was filed for VERSAMAB with the United States Patent and Trademark Office. The USPTO has given the VERSAMAB trademark a serial number of 97148707. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Integral Molecular, Inc.. The VERSAMAB trademark is filed in the Chemical Products category with the following description:

Biochemicals, namely, monoclonal antibodies for in vitro and in vivo scientific research, and non-medical diagnostic purposes
versamab

General Information

Serial Number97148707
Word MarkVERSAMAB
Filing DateTuesday, November 30, 2021
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7502927
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements

Pseudo MarkVERSA MAB
Goods and ServicesBiochemicals, namely, monoclonal antibodies for in vitro and in vivo scientific research, and non-medical diagnostic purposes

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, December 3, 2021
Primary Code001
First Use Anywhere DateTuesday, February 27, 2024
First Use In Commerce DateTuesday, February 27, 2024

Trademark Owner History

Party NameIntegral Molecular, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameIntegral Molecular, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameIntegral Molecular, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Friday, December 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 3, 2021NEW APPLICATION ENTERED
Friday, September 9, 2022ASSIGNED TO EXAMINER
Tuesday, September 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 13, 2023SOU EXTENSION 2 FILED
Monday, May 15, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 15, 2023SOU EXTENSION 1 FILED
Monday, May 15, 2023SOU EXTENSION 1 GRANTED
Wednesday, May 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 2 GRANTED
Thursday, May 30, 2024USE AMENDMENT FILED
Thursday, May 30, 2024SOU EXTENSION 3 FILED
Thursday, May 30, 2024USE AMENDMENT FILED
Thursday, May 30, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2024USE AMENDMENT FILED
Thursday, May 30, 2024TEAS STATEMENT OF USE RECEIVED
Monday, July 8, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, July 8, 2024SOU EXTENSION 3 GRANTED
Monday, July 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 5, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 5, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

versamab research medical diagnostic purposes scientific vivo namely monoclonal antibodies vitro